# Atorvastatin Study in Cardiovascular Disease Risk

> **NCT02392416** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 900 (actual)

## Conditions studied

- Hypercholesterolemia
- Dyslipidemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02392416
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 900 (ACTUAL)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02392416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02392416, "Atorvastatin Study in Cardiovascular Disease Risk". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02392416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*